{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:02:06Z","timestamp":1790820126672,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":86,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Chiesi Pharma AB, Nordics, Sweden","award":["SiASMARTer"],"award-info":[{"award-number":["SiASMARTer"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"DOI":"10.1186\/s12890-026-04454-1","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T10:25:45Z","timestamp":1783419945000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Study protocol: a 52-week, multicentre, observational, prospective study on the use of a smart platform connected to a single-inhaler triple therapy (ICS\/LABA\/LAMA) to evaluate effectiveness on treatment adherence and inhaler technique in patients with poorly controlled asthma"],"prefix":"10.1186","volume":"26","author":[{"given":"Jonas Aggerholm","family":"Baekdal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolai","family":"Krogh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gajanan","family":"Sakhare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Bendstrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte Suppli","family":"Ulrik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes Martin","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"key":"4454_CR1","unstructured":"Asthma Management and Prevention - Global Initiative for Asthma - GINA. Available from: https:\/\/ginasthma.org\/now-available-2024-summary-guide-for-asthma-management-and-prevention\/.\u00a0Cited 2025 Feb 10."},{"key":"4454_CR2","unstructured":"The Global Asthma. Report. 2018. Available from: https:\/\/globalasthmareport.org\/2018\/index.html.\u00a0Cited 2025 Feb 10."},{"key":"4454_CR3","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3389\/fped.2019.00246","volume":"7","author":"SC Dharmage","year":"2019","unstructured":"Dharmage SC, Perret JL, Custovic A. Epidemiology of Asthma in Children and Adults. Front Pediatr. 2019;7:246.","journal-title":"Front Pediatr"},{"issue":"1","key":"4454_CR4","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1164\/rccm.200801-060ST","volume":"180","author":"HK Reddel","year":"2009","unstructured":"Reddel HK, Taylor DR, Bateman ED, Boulet LP, Boushey HA, Busse WW, et al. An Official American Thoracic Society\/European Respiratory Society Statement: Asthma Control and Exacerbations: Standardizing Endpoints for Clinical Asthma Trials and Clinical Practice. Am J Respir Crit Care Med. 2009;180(1):59\u201399.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"4454_CR5","doi-asserted-by":"publisher","first-page":"2","DOI":"10.5334\/aogh.2412","volume":"85","author":"O Enilari","year":"2019","unstructured":"Enilari O, Sinha S. The Global Impact of Asthma in Adult Populations. Annals Global Health. 2019;85(1):2.","journal-title":"Annals Global Health"},{"issue":"1","key":"4454_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40733-016-0029-3","volume":"3","author":"C Nunes","year":"2017","unstructured":"Nunes C, Pereira AM, Morais-Almeida M. Asthma costs and social impact. asthma res pract. 2017;3(1):1.","journal-title":"asthma res pract"},{"issue":"2","key":"4454_CR7","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1183\/09031936.00075614","volume":"45","author":"M Engelkes","year":"2015","unstructured":"Engelkes M, Janssens HM, De Jongste JC, Sturkenboom MCJM, Verhamme KMC. Medication adherence and the risk of severe asthma exacerbations: a systematic review. Eur Respir J. 2015;45(2):396\u2013407.","journal-title":"Eur Respir J"},{"key":"4454_CR8","doi-asserted-by":"publisher","unstructured":"Ducharme FM, Ni Chroinin M, Greenstone I, Lasserson TJ. Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthma. Cochrane Airways Group, editor. Cochrane Database of Systematic Reviews. 2010. Available from: https:\/\/doi.org\/10.1002\/14651858.CD005533.pub2.\u00a0Cited 2025 Feb 10.","DOI":"10.1002\/14651858.CD005533.pub2"},{"issue":"12","key":"4454_CR9","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1080\/02770903.2021.2022160","volume":"59","author":"F Braido","year":"2022","unstructured":"Braido F, Tiotiu A, Guidos-Fogelbach G, Baiardini I, Cosini F, Correia De Sousa J, et al. Manifesto on inhaled triple therapy in asthma: an Interasma (Global Asthma Association \u2013 GAA) document. J Asthma. 2022;59(12):2402\u201312.","journal-title":"J Asthma"},{"key":"4454_CR10","unstructured":"GINA-Severe-Asthma-Guide-2024-WEB-WMS.pdf. Available from: https:\/\/ginasthma.org\/wp-content\/uploads\/2024\/11\/GINA-Severe-Asthma-Guide-2024-WEB-WMS.pdf.\u00a0Cited 2025 Feb 26."},{"key":"4454_CR11","doi-asserted-by":"publisher","first-page":"102333","DOI":"10.1016\/j.pupt.2024.102333","volume":"87","author":"D Bagnasco","year":"2024","unstructured":"Bagnasco D, Ansotegui I, Baiardini I, Benfante A, Bernstein JA, Bikov A, et al. Triple inhaled therapy in asthma: Beliefs, behaviours and doubts. Pulm Pharmacol Ther. 2024;87:102333.","journal-title":"Pulm Pharmacol Ther"},{"key":"4454_CR12","doi-asserted-by":"publisher","first-page":"106915","DOI":"10.1016\/j.rmed.2022.106915","volume":"200","author":"M Cazzola","year":"2022","unstructured":"Cazzola M, Braido F, Calzetta L, Matera MG, Piraino A, Rogliani P, et al. The 5T approach in asthma: Triple Therapy Targeting Treatable Traits. Respir Med. 2022;200:106915.","journal-title":"Respir Med"},{"issue":"2","key":"4454_CR13","doi-asserted-by":"publisher","first-page":"e218","DOI":"10.1016\/S2214-109X(22)00506-X","volume":"11","author":"L Garc\u00eda-Marcos","year":"2023","unstructured":"Garc\u00eda-Marcos L, Chiang CY, Asher MI, Marks GB, El Sony A, Masekela R, et al. Asthma management and control in children, adolescents, and adults in 25 countries: a Global Asthma Network Phase I cross-sectional study. Lancet Global Health. 2023;11(2):e218\u201328.","journal-title":"Lancet Global Health"},{"issue":"1","key":"4454_CR14","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.rmed.2012.09.017","volume":"107","author":"D Price","year":"2013","unstructured":"Price D, Bosnic-Anticevich S, Briggs A, Chrystyn H, Rand C, Scheuch G, et al. Inhaler competence in asthma: Common errors, barriers to use and recommended solutions. Respir Med. 2013;107(1):37\u201346.","journal-title":"Respir Med"},{"issue":"1","key":"4454_CR15","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s40521-023-00328-7","volume":"10","author":"AA Eikholt","year":"2023","unstructured":"Eikholt AA, Wiertz MBR, Hew M, Chan AHY, Van Boven JFM. Electronic Monitoring Devices to Support Inhalation Technique in Patients with Asthma: a Narrative Review. Curr Treat Options Allergy. 2023;10(1):28\u201352.","journal-title":"Curr Treat Options Allergy"},{"issue":"2","key":"4454_CR16","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.chest.2016.03.041","volume":"150","author":"J Sanchis","year":"2016","unstructured":"Sanchis J, Gich I, Pedersen S. Systematic Review of Errors in Inhaler Use. Chest. 2016;150(2):394\u2013406.","journal-title":"Chest"},{"issue":"1","key":"4454_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s41030-018-0051-0","volume":"4","author":"SZ Bosnic-Anticevich","year":"2018","unstructured":"Bosnic-Anticevich SZ, Cvetkovski B, Azzi EA, Srour P, Tan R, Kritikos V. Identifying Critical Errors: Addressing Inhaler Technique in the Context of Asthma Management. Pulm Ther. 2018;4(1):1\u201312.","journal-title":"Pulm Ther"},{"key":"4454_CR18","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.rmed.2019.09.008","volume":"158","author":"H Chrystyn","year":"2019","unstructured":"Chrystyn H, Audibert R, Keller M, Quaglia B, Vecellio L, Roche N. Real-life inhaler adherence and technique: Time to get smarter! Respir Med. 2019;158:24\u201332.","journal-title":"Respir Med"},{"issue":"1","key":"4454_CR19","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jaci.2003.09.008","volume":"113","author":"RA Nathan","year":"2004","unstructured":"Nathan RA, Sorkness CA, Kosinski M, Schatz M, Li JT, Marcus P, et al. Development of the asthma control test: A survey for assessing asthma control. J Allergy Clin Immunol. 2004;113(1):59\u201365.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"4454_CR20","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.jaci.2006.01.011","volume":"117","author":"M Schatz","year":"2006","unstructured":"Schatz M, Sorkness CA, Li JT, Marcus P, Murray JJ, Nathan RA, et al. Asthma Control Test: reliability, validity, and responsiveness in patients not previously followed by asthma specialists. J Allergy Clin Immunol. 2006;117(3):549\u201356.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"4454_CR21","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1034\/j.1399-3003.1999.14a08.x","volume":"14","author":"EF Juniper","year":"1999","unstructured":"Juniper EF, Guyatt GH, Cox F, m, Ferrie PJ, King DR. Development and validation of the Mini Asthma Quality of Life Questionnaire. Eur Respir J. 1999;14(1):32.","journal-title":"Eur Respir J"},{"key":"4454_CR22","doi-asserted-by":"crossref","unstructured":"Dweik RA, Boggs PB, Erzurum SC, Irvin CG, Leigh MW, Lundberg JO, et al. Am Thorac Soc Documents. 2011. p. 184.","DOI":"10.1164\/rccm.9120-11ST"},{"issue":"1","key":"4454_CR23","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/ACI.0000000000000132","volume":"15","author":"F Braido","year":"2015","unstructured":"Braido F, Baiardini I, Blasi F, Pawankar R, Canonica GW. Adherence to asthma treatments: \u2018we know, we intend, we advocate\u2019. Curr Opin Allergy Clin Immunol. 2015;15(1):49\u201355.","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"6","key":"4454_CR24","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/j.jaci.2004.09.028","volume":"114","author":"LK Williams","year":"2004","unstructured":"Williams LK, Pladevall M, Xi H, Peterson EL, Joseph C, Lafata JE, et al. Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma. J Allergy Clin Immunol. 2004;114(6):1288\u201393.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"4454_CR25","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1111\/j.1398-9995.2008.01877.x","volume":"64","author":"L Lasmar","year":"2009","unstructured":"Lasmar L, Camargos P, Champs NS, Fonseca MT, Fontes MJ, Ibiapina C, et al. Adherence rate to inhaled corticosteroids and their impact on asthma control. Allergy. 2009;64(5):784\u20139.","journal-title":"Allergy"},{"issue":"3","key":"4454_CR26","doi-asserted-by":"publisher","first-page":"455","DOI":"10.4187\/respcare.03200","volume":"60","author":"CB B\u00e5rnes","year":"2015","unstructured":"B\u00e5rnes CB, Ulrik CS. Asthma and adherence to inhaled corticosteroids: current status and future perspectives. Respir Care. 2015;60(3):455\u201368.","journal-title":"Respir Care"},{"issue":"5","key":"4454_CR27","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.jaip.2016.03.002","volume":"4","author":"F Braido","year":"2016","unstructured":"Braido F, Chrystyn H, Baiardini I, Bosnic-Anticevich S, Van Der Molen T, Dandurand RJ, et al. Trying, But Failing \u2014 The Role of Inhaler Technique and Mode of Delivery in Respiratory Medication Adherence. J Allergy Clin Immunology: Pract. 2016;4(5):823\u201332.","journal-title":"J Allergy Clin Immunology: Pract"},{"issue":"1","key":"4454_CR28","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41533-021-00218-y","volume":"31","author":"J Sulku","year":"2021","unstructured":"Sulku J, Br\u00f6ms K, H\u00f6gman M, Janson C, Lisspers K, Malinovschi A, et al. Critical inhaler technique errors in Swedish patients with COPD: a cross-sectional study analysing video-recorded demonstrations. npj Prim Care Respir Med. 2021;31(1):5.","journal-title":"npj Prim Care Respir Med"},{"key":"4454_CR29","doi-asserted-by":"publisher","first-page":"117727191982655","DOI":"10.1177\/1177271919826550","volume":"14","author":"FC De Abreu","year":"2019","unstructured":"De Abreu FC, Da Silva J\u00fanior JLR, Rabahi MF. The Fraction Exhaled Nitric Oxide as a Biomarker of Asthma Control. Biomark Insights. 2019;14:1177271919826550.","journal-title":"Biomark Insights"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-026-04454-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-026-04454-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-026-04454-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:26:40Z","timestamp":1790818000000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12890-026-04454-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4454"],"URL":"https:\/\/doi.org\/10.1186\/s12890-026-04454-1","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,7]]},"assertion":[{"value":"10 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A pre-assessment was conducted to determine whether the SiA\u00aeSMARTer platform was classified as a medical or non-medical device by the Danish Medicines Agency (DMA). As it was classified as a non-medical device, ethical approval for the present observational study was obtained from The Regional Committees on Health Research Ethics for Central Denmark Region (approval number: 1-10-72-193-23). Individual written informed consent will be obtained from each study participant before enrolment. The study will be conducted in accordance with Good Clinical Practice (GCP) guidelines, the Declaration of Helsinki, and the regulatory requirements of Denmark. Permission to use the ACT (Asthma Control Test) was granted by IQVIA Inc., and all licensing and permission requests should be directed to IQVIA Inc. at COAsolutions@iqvia.com.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"JAB has received fees for lectures from Novo Nordisk and travel\/conference grant from Chiesi Pharma outside the submitted work. NK is employed by Chiesi Pharma AB Nordics, the sponsor of the study. GS is cofounder of Briota ApS, providing the SiA\u00aeSMARTer platform for the study. EB declare no competing interest regarding this project. CSU has received fees for lectures, participation in advisory boards etc. from Chiesi, AstraZeneca, GSK, TEVA, Pfizer, Sanofi, IQVIA, Takeda, Roche, Novo Nordisk, Hikma Pharmaceuticals, Berlin Chemie, Boehringer Ingelheim, TFF Pharmaceuticals and Novartis outside the submitted work. JMS has no conflicts of interest regarding this project.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"444"}}